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ABSTRACT Different algorithms have been proposed to increase the diagnos-
tic capacity of syphilis. We analyzed three common algorithms for de-
tecting suspected syphilis cases in low prevelance Turkish population. 
The study included a total of 340 clinical serum samples from adults 
throughout Turkey, who had syphilis as a clinical preliminary diagnosis 
and  were positive on at least one of the following tests: Rapid Plasma 
Reagin (RPR), Treponema pallidum Haemagglutination test (TPHA) and 
FTA-abs Ig. In adittion to percent agreement, kappa coefficients were 
calculated to compare the conformity between the three algorithms. 
Both the reverse and the ECDC algorithms had higher diagnostic effica-
cy than the conventional algorithm. The sensitivity/specificity/ accuracy 
of conventional, reverse and ECDC algorithms were 51.3%/86.1%/55%; 
80.9%/86.1%/81.4% and 80.9%/100%/82.9% respectively. The interrater 
reliability was moderate for conventional-reverse algorithm (73.53%; 
к=0.484; 95%CI=0.41-0.56; p=0.001) and conventional-ECDC algorithm 
(72.06%; к=0.454; 95% CI= 0.37-0.54; p=0.001), and near perfect for re-
verse-ECDC algorithm (98.53%; к=0.963; 95% CI=0.93-0.99; p=0.0001). 
Our data support the use of ECDC algorithm in serological diagnosis of 
syphilis. It may increase the diagnostic capacity if treponemal tests are 
used for screening, and then positive results are confirmed with a dif-
ferent and second treponemal test.
Key woRDS: Treponema pallidum, syphilis, serology, algorithm, sexu-
ally transmitted infections
INTRoDUCTIoN
Syphilis caused by a spirochet Treponema palli-
dum subsp. pallidum has been an important public 
health problem for many years all over the world 
(1). The inability of culturing the bacteria easily has 
forced laboratorians to search for alternative meth-
ods for diagnosing syphilis (2). Direct diagnosis is 
based on the examination of specimens obtained 
from genital ulcers or dermatologic lesions by dark 
field microscopy. Although the dark field micros-
copy is a reliable diagnostic tool, the accuracy of 
the test is affected by the experience of the person 
performing the test, the number of live treponemas 
in the lesion and the presence of nonpathogenic 
treponemes in the lesions (3). While recent advanc-
es in molecular methods, such as PCR, look prom-
ising, the test largely remains a research tool as it 
is still not available in many diagnostic laboratories 
(4). 
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Serological tests for the detection of nontrepone-
mal antibodies or antibodies against Treponema pal-
lidum in all stages of infection, remain the mainstay 
of diagnosis. Non-treponemal tests are largely used 
to monitor the status of infection, while treponemal 
tests are primarily used to confirm the presence of in-
fection. The sensitivity and specificity of treponemal 
and nontreponemal tests vary with the type of test 
as well as the stage of infection. Antibodies detected 
by treponemal tests arise earlier than those detected 
by non-treponemal tests and typically remain detect-
able for life, even after successful treatment (4-5). 
There are currently two commonly used ap-
proaches for the serological diagnosis of syphilis: the 
conventional algorithm and the reverse algorithm. In 
the conventional algorithm, a non-treponemal test, 
such as the Venereal Disease Research Laboratory 
(VDRL) or Rapid Plasma Reagin (RPR) test, with posi-
tive results is confirmed using a specific treponemal 
test such as TPHA or FTA-abs (6,7,8). However non-
treponemal test based screening may not always 
be followed by a treponamal test, especially in re-
source-limited settings, and may therefore miss pre-
viously treated, early untreated, and late latent cases 
(9,10). Therefore, positive non-treponemal test results 
should be confirmed with treponemal tests, such as 
Fluorescent Treponemal Antibody-absorption (FTA-
abs) test, Treponema pallidum Hemagglutination test 
(TPHA) or ELISA tests that detect specific antibodies 
against T. pallidum proteins (6,7,11,12). 
The use of a single serologic test is often insuffi-
cient in the determination of false negative or positive 
test results. For this reason, different algorithms have 
been proposed to increase the diagnostic capacity. In 
the serological diagnosis of syphilis, two algorithms 
are defined as conventional (conventional-CDC) and 
reverse (reverse and ECDC) (13). The conventional algo-
rithm is the most widely accepted method worldwide, 
which is recommended by the CDC, and involves con-
firmation of positive non-treponemal tests with one of 
the treponemal tests (8,10,11,14-17). In recent years, 
the reverse algorithm, in which two implementation 
schemes are defined, is the alternative algorithm pro-
posed for conventional approach. In the first scheme 
of reverse algorithm, treponemal tests are first per-
formed as a screening test and the positive results ob-
tained are confirmed by non-treponemal tests. When 
the non-treponemal test result is negative, a second, 
different treponemal test is used (11). In the second 
scheme which is proposed by the ECDC, non-trepone-
mal test is not used, and the results that are positive by 
screening with the treponemal test are confirmed by a 
second different treponemal test (1,18-20).
In this study, we aimed to evaluate the compat-
ibility of the three different algorithms (conventional, 
reverse and ECDC) which are used in syphilis diagno-
sis nowadays.
MeTHoDS
Syphilis diagnostic tests are conducted in Public 
Health Institution of Turkey, Sexually Transmitted Dis-
eases Laboratory which is accredited for syphilis tests. 
Patient sera with syphilis as a clinical preliminary di-
agnosis, which were tested routinely and stored at -
80° C between 2013-2015 years were evaluated com-
paratively. A total of 340 serum samples positive by 
either RPR, (Omega, UK), TPHA, (Plasmatec, UK) and 
FTA-abs IgG/IgM (Euroimmun, Germany) tests were 
included in the study. All the serological testing was 
performed on the same specimen according to the 
manufacturers’ recommendations, and the results of 
all the tests were reported simultaneously. Conven-
tional, reverse and ECDC algorithms were evaluated 
for compatibility with each other.
Conventional algorithm: The nontreponemal 
test (RPR test) was used as a screening test. The posi-
tive non-treponemal test results were confirmed by 
one of the treponemal tests (TPHA test). 
Reverse algorithm: In the first stage, treponemal 
test (TPHA) was used and positive results were con-
firmed by non-treponemal test (RPR test). A second 
different treponemal test (FTA-abs test) was applied 
to the samples detected negative by the non-trepo-
nemal test. 
ECDC algorithm: After screening with treponemal 
test (TPHA test), positive results were confirmed by a 
second different treponemal test (FTA-abs). 
Statistical analysis: The diagnostic accuracy of 
the tests was assessed using the SPSS 15.0 program 
(IBM, USA). Percent agreement and к (kappa) coeffi-
cient analysis were used to determine the correspon-
dence between the algorithms. The percentage of 
agreement between the results according to к val-
ues were categorized as near perfect (0.81-1.0), sub-
stantial (0.61-0.8), moderate (0.41-0.6), fair (0.21-0.4), 
slight (0-0.2), or poor (<0) (21). 
ReSULTS
Of 340 serum samples tested, 198 (58.2%), 262 
(77%), 304 (89.4%) were positive by RPR, TPHA and 
FTA-abs respectively. 161 (81.3%) of RPR-positive 
samples and 101 (71.1%) of RPR-negative samples 
were positive on TPHA test. RPR-positive and TPHA-
negative 37 (10.8%) samples were considered as bio-
logical false positive reaction (Figure 1). According to 
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the gold standard FTA-abs test as the gold standart 
method, sensitivity, specificity and accuracy of RPR 
and TPHA tests were; 56.9%, 30.5%, 54.1%; 80.9, 55.5%, 
78.2%, respectively. RPR test results showed slight 
agreement with TPHA (59.4%; к=0.109; 95%CI=0.01-
0.20; p=0.08) and TPHA showed fair agreement with 
FTA-abs test results (78.24%; к=0.241; 95%CI=0.12-
0.36; p=0.001). The interrater reliability was moderate 
for conventional-reverse algorithm (73.53%; к=0.484; 
95%CI=0.41-0.56; p=0.001) and conventional-ECDC 
algorithm (77.06%; к=0.454; 95% CI=0.37-0.54; 
p=0.001) and near perfect for reverse-ECDC algorithm 
(98.53%; к=0.963; 95% CI=0.93-0.99; p=0.0001). 
Of the 304 samples detected positively by FTA-
abs, 161 (52.9%) were positive with the conventional 
algorithm, 251 (82.5%) with the reverse algorithm and 
246 (80.9%) with the ECDC algorithm. Furthermore, 
the sensitivity of the conventional testing algorithm 
was only 51.3%, with the lowest negative predictive 
value of 17.3%. The sensitivity of reverse and ECDC 
algorithm was found to be 80.9% and the specificity 
was found to be the highest in the ECDC algorithm 
(100%). The algorithms’ specificity, positive predic-
tive value, negative predictive value and accuracy are 
presented in Table 1. When conventional, reverse and 
ECDC algorithms were evaluated for false negativity 
and positivity, false negativity was 48.7%, 19.1%, and 
19.1%, respectively. False positivity was 13.8%, 13.8% 
and 0%, respectively. Positive test result probability 
ratios were 3.6%, 5.8% and 80.9% according to con-
ventional, reverse and ECDC tests, respectively. Nega-
tive test result probability ratios were 56.5%, 22.1% 
and 0.19%, respectively. Both the reverse and ECDC 
algorithm had high accuracy in the diagnosis of syph-
ilis. However, the ECDC algorithm is slightly different 
from the reverse algorithm as it does not involve a 
nontreponemal test for diagnosis. Therefore, we com-
pared these 2 testing algorithms using к coefficient 
analysis. The result indicated a high degree of consis-
tency between the reverse and the ECDC algorithms 
(Figure 1 and Table 1).
 DISCUSSIoN AND CoNCLUSIoN
The diagnosis of syphilis is challenging and is gen-
erally made by serologic tests (12). Currently, there 
are a few studies that evaluate different algorithms 
in detail in terms of syphilis. Although the findings 
in our study are critical in assessing the performance 
of the algorithms, an inherent limitation of the study 
was the lack of detailed clinical information on the 
patient’s symptoms/signs or stage of the  disease. Be-
cause of this limitation, we were unable to evaluate 
the diagnostic accuracy of the algorithms compared 
with clinical diagnosis. As the incidence of the disease 
is not known exactly in Turkey, we sought to directly 
compare the algorithms in a patient population with 
a low prevalence of syphilis.
In our study, 58.2% of the total 340 sera detected 
positively by any test were found to be positive with 
RPR, 262 (77.05%) with TPHA and 304 (89.41%) with 
FTA-abs. RPR and TPHA are widely used in our country 
and there is a need for a standard algorithm for the 
serological diagnosis of syphilis. 71.1% of the RPR-ne-
gative samples were detected as positive with TPHA 
and were defined as false-negatives. Non-treponemal 
tests that detect antibodies against cardiolipin are 
not specific to treponemal infections. In our study, 37 
(10.8%) of all the samples positive with a RPR test were 
negative with TPHA test and were defined as false-po-
sitives. False positive non-treponemal test results may 
be seen in many conditions such as HIV, SLE, tubercu-
losis, rickettsial infection, spirochetal infections other 
than syphilis, bacterial endocarditis, autoimmune di-
seases, vaccination, pregnancy, intravenous drug use 
and advanced age not related to syphilis (9,10).
The most commonly used approach in diagnosis 
is based on screening with non-treponemal tests and 
confirmaton of positive results with treponemal tests 
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as in the conventional algorithm (11). This approach is 
based on studies showing that RPR screening is more 
compatible with disease activity than the reverse al-
gorithm (11,22). In our study, 52.9% of the cases were 
defined as syphilis with the conventional algorithm. 
In the conventional algorithm, negative non-trepo-
nemal test results are not evaluated by treponemal 
tests. Since 71.1% of the RPR-negative patients were 
positive with the treponemal test, it is thought that 
the conventional algorithm was insufficient in syp-
hilis diagnosis. Tests that detect specific antibodies 
against treponemal antigens have a higher sensitivity 
than non-treponemal tests so this issue changed the 
conventional approach (6). However, as treponemal 
tests are more difficult and expensive, their use as a 
screening test is limited. Furthermore, unlike non-
treponemal tests, which usually become negative 
with effective treatment, treponemal tests usually 
remain life-long positive. Hence, treponemal tests 
are not used in the follow-up of treatment efficacy 
as are non-treponemal tests (23). The US Center for 
Disease Control (CDC) reported that the percentage 
of patients with false-positive treponemal screening 
in low-prevalence populations was especially high as 
it was 2.9-times greater than those in high prevelan-
ce populations (24). Accordingly, the implementation 
of the reverse algorithm has created a substantial 
amount of confusion and concern among healthcare 
providers and patients. Therefore, the CDC continues 
to recommend the conventional algorithm (24).
In line with the results obtained from studies 
(1,18,25), most laboratories apply the reverse algo-
rithm, which includes a non-treponemal test. When 
screening with the treponemal test, a larger number 
Figure 1. Different testing algorithms for syphilis serological diagnosis. Abbreviations: ECDC, European Centre for Disease 
Prevention and Control; RPR, Rapid Plasma Reagin; TPHA, Treponema pallidum Hemagglutination Assay; FTA-abs, Fluorescent 
Treponemal Antibody Absorbtion Test; BFP, biological false positive
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of positive test results can be obtained than with the 
conventional algorithm, but a significant number of 
them can be found to be negative with RPR test, de-
pending on stage and treatment status (20,26). In our 
study, the  screening for syphilis using a treponemal 
test detected a higher number of patients with reac-
tive results compared to conventional screening. Sin-
ce 1982, WHO recommends screening and diagnosis 
of syphilis by non-treponemal and treponemal tests 
and European countries propose screening with tre-
ponemal tests (17). Binnicker et al. (12) reported that 
the reverse algorithm resulted in higher false-positi-
ve results than the conventional algorithm, and the 
false positive rates for reverse and conventional al-
gorithms were 0.6% and 0% respectively. Similarly, in 
the study of CDC (11), the false positive rate with the 
reverse algorithm was determined to be 0.6%. In our 
study, the false positive rates for conventional, rever-
se and ECDC algorithms were determined as 13.8%, 
13.8% and 0%, respectively, and higher false positivi-
ties were observed with reverse algorithm according 
to other studies (11,12). Despite our findings, further 
research is required to understand the real cause of 
false positivity. Similar to Binnicker et al (12) recom-
mendation, we consider that the diagnostic capacity 
of reverse algorithm is higher than the conventional 
method, and for this reason we emphasize that it is 
appropriate to use it in the diagnosis. In adittion, the 
results we have obtained show that in reverse algorit-
hm ECDC scheme has high sensitivity, specificity and 
accuracy, and because of the low false positivity, the 
substitution of the conventional method may result 
with increasing sensitivity in diagnosis. 
The screening stategy recommended by the 
ECDC involves a primary treponemal screening test 
followed by a second confirmatory treponemal test 
(20,27). The results obtained from a large cohort (1), 
as well as our data support performing ECDC algorit-
hm for syphilis screening in Turkish population also. 
The direct comparison of the revers and ECDC algo-
rithm in our study gave an overall percent agreement 
and kappa value of 98.53% and 0.963, suggesting 
that a nontreponemal test is unnecessary for syphilis 
serodiagnosis. When the diagnostic capacity of both 
tests is compared with the conventional algorithm, 
the use of reverse and ECDC algorithms is proposed. 
Similar to the data obtained from our study, it has 
been reported by Tong et al (1) that reverse and the 
ECDC algorithms have a higher diagnostic capacity 
than the conventional algorithm. We also found al-
most perfect agreement (к=0.996) between reverse 
and ECDC algorithms. This finding was similar to our 
study (к = 0.963). However, as Simcic et al (28) repor-
ted, we also thought that the use of a treponemal test 
for screening purposes and confirmation of the posi-
tive results with a second (ECDC algorithm) will inc-
rease sensitivity and specificity. In the cases that the 
first treponemal test is positive and the confirmatory 
treponemal test is negative, then it is not clear whet-
her the first screening test is a false positive or is more 
sensitive. This is a disadvantage of the algorithm, so 
it would be advisable for a laboratory to select two 
treponemal assays with comparable performance to 
avoid discrepant results (27).
There are limited studies on the comparison of 
syphilis diagnostic algorithms in Turkey. In the study 
conducted by Ozbek et al (6), serum samples were ex-
amined by an ELISA test using treponemal antigens. 
According to the results of the study, it was suggest-
ed that false-positive results could be obtained by 
ELISA test. Similar to our study, it has been concluded 
that the results of positive treponemal test must be 
confirmed by another treponemal test and RPR test 
should be used in order to determine the activity 
of the infection and for the treatment follow-up (6). 
There is also a need for the evaluation of ELISA tests 
since they are frequently used as screening tests in 
order to obtain an appropriate algorithm for the pop-
ulation.
The most important limiting factor in this study 
was the fact that there are very limited data on syphi-
lis prevalence in our country.  The actual incidence of 
syphilis is not known because of differences in the 
algorithms used, inappropriate test selection, and 
empirical treatment without confirmation of positive 
test results. Additionally, inappropriate patient selec-
tion and lack of nationwide testing strategy playes a 
role in ambigious estimation of incidence. For these 
reasons, a laboratory-based surveillance network 
should be established throughout the country and 
standardization of the tests used in syphilis serology 
should be one of the main targets. Syphilis diagnostic 
algorithms applied in different countries vary signifi-
cantly depending on the considerations (29). Given 
the pros and cons of each diagnostic algorithm, the 
decision of using a treponemal or nontreponemal 
test as the first screening test should be based on a 
combination of factors: local syphilis prevelance, the 
expected workload and the available budget for la-
bor and consumables.
In conclusion, we suggested that non-trepone-
mal tests should be replaced by treponemal tests 
in syphilis diagnosis as a first screening test. This re-
quires new diagnostic algorithms to be established. 
According to our results, using treponemal test for 
screening purposes would increase the diagnostic 
sensitivity and specificity. Positive results should also 
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be confirmed with a different second treponemal test 
(ECDC algorithm). Once syphilis has been diagnosed, 
nontreponemal test can be performed to assess dis-
ease activity and follow treatment status.
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